Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 208 clinical trials
featured
PANOVA-3 (Pancreatic Adenocarcinoma)

People with pancreatic adenocarcinoma are asked to participate in a research study being conducted by White Plains Hospital.  

adenocarcinoma
pancreatic adenocarcinoma
  • 12 views
  • 02 Aug, 2019
  • 1 location
featured
Pancreatic Adenocarcinoma - Advanced

Pancreatic Adenocarcinoma - Advanced

  • 150 views
  • 08 Nov, 2020
  • 1 location
featured
A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma

A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma

paclitaxel
adenocarcinoma
pancreatic adenocarcinoma
gemcitabine
  • 178 views
  • 23 Nov, 2020
  • 1 location
featured
RTOG 0848: A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma.

RTOG 0848: A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma.

  • 620 views
  • 08 Nov, 2020
  • 1 location
featured
A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (PhIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (PhIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

adenocarcinoma
erlotinib
  • 178 views
  • 24 Nov, 2020
  • 1 location
featured
A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (PhIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (PhIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma

adenocarcinoma
erlotinib
  • 182 views
  • 24 Nov, 2020
  • 1 location
A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer Compared to Nab-paclitaxel+Gemcitabine Treatment

The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxaliplatin compared to nab-paclitaxel + gemcitabine treatment in improving the overall survival of patients not previously treated for …

  • 31 views
  • 26 Dec, 2020
  • 240 locations
Translational Research on Locally Advanced Pancreatic Adenocarcinoma

The purpose of this study is to find the best neoadjuvant therapy for pancreatic adenocarcinoma.

chemoradiotherapy
adenocarcinoma
advanced pancreatic adenocarcinoma
pancreatic adenocarcinoma
  • 4 views
  • 08 Nov, 2020
  • 1 location
Neoadjuvant GMCI Plus Chemoradiation for Advanced Non-Metastatic Pancreatic Adenocarcinoma

The purpose of this study is to evaluate Gene Mediated Cytotoxic Immunotherapy (GMCI) in combination with standard of care chemoradiation and surgery for borderline resectable and unresectable locally advanced pancreatic cancer in patients who have completed induction chemotherapy. GMCI kills tumor cells and creates an immune stimulatory environment in the …

cancer
tumor cells
neutrophil count
metastatic pancreatic adenocarcinoma
  • 0 views
  • 16 Dec, 2020
  • 5 locations
Trial of NanoPac in Subjects With Locally Advanced Pancreatic Adenocarcinoma

Open-label, dose-escalating, Phase IIa trial of NanoPac to treat subjects with locally advanced pancreatic adenocarcinoma via direct intratumoral injection.

  • 44 views
  • 04 Nov, 2020
  • 4 locations